The Victorian Cancer Agency is a team within the Department of Health that funds translational cancer research to improve clinical practice and outcomes for Victorian people impacted by cancer.
The Victorian Cancer Agency’s research grants have been supporting innovation and excellence in cancer research since 2006, investing more than $320 million into translational research and infrastructure.
The following funding schemes are now open and will close at 2.00 pm AEST on Tuesday 26 July 2022:
Applications are encouraged from multiple disciplines across the translational cancer research continuum.
Please note the VCA Funding Round is commencing earlier this year in accordance with caretaker conventions pending the outcome of the 2022 November Victorian State Election.
This year Early and Mid-Career research fellowships will incorporate a Low-Survival Cancer Philanthropic Research Fellowship scheme, which will involve up to four additional non-financial partnerships with philanthropic organisations to provide a named fellowship to the top ranked applicant in that tumour stream.
The partner organisations are LiverWELL, Lung Foundation Australia, Ovarian Cancer Australia and Pancare Foundation.
The objective of this scheme will be the prioritisation of low survival cancer research and increased awareness of the work of the low survival cancer philanthropic partners.
To be eligible the project must demonstrate a primary focus on one or more of the following low survival cancers; ovarian, lung, liver, or pancreas. The proposed work must relate to the causes, prevention, support and wellbeing, diagnosis or treatment of the cancer. Please see fellowship guidelines on the VCA website for further details.
Note: Applicants interested in this scheme must meet all other eligibility criteria required for the VCA Early Career or Mid-Career Research Fellowship scheme.
More information, including guidelines, funding rules and a link to the application forms can be found on our website: http://www.victoriancanceragency.vic.gov.au.